The potential impact of bisphosphonates on major adverse cardiovascular events: a study of 1,097,406 patients

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Integrating insights: from biomarkers to therapeutics in the management of acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by